Iain Mackay has been group finance director of HSBC Holdings since 2010
GlaxoSmithKline has recruited HSBC's Iain Mackay as its next chief financial officer.
Emma Walmsley, GlaxoSmithKline's chief executive officer, said Mackay was a "proven chief financial officer of a complex, regulated global organisation". She added that he had a "track record of driving cost, cash and capital allocation discipline to deliver strategy".
Mackay will join GlaxoSmithKline on 14 January 2019 from global bank HSBC Holdings, where he has been group finance director for the past eight years.
He will take over from Simon Dingemans who is retiring from GlaxoSmithKline in May 2019 (click here to read the News story).
GlaxoSmithKline said Dingemans would remain chief financial officer through March 2019, with Mackay taking formal accountability as chief financial officer from 1 April 2019. Mackay will join the Corporate Executive Team and the Board from 14 January 2019.
A chartered accountant, Mackay worked for General Electric, Schlumberger Dowell and Price Waterhouse before joining HSBC in 2007.
Mackay is a trustee of the British Heart Foundation and an independent member of the Court of the University of Aberdeen in Scotland.
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE